ID
30203
Descripción
Study ID: 108414 Clinical Study ID: DBU108414 Study Title: TXA107979: A placebo-controlled, single blind, randomized two part study to investigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01036061 https://clinicaltrials.gov/ct2/show/NCT01036061 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK618334 Study Indication: Substance Dependence Documentation part: Pharmacokinetics Urine
Link
https://clinicaltrials.gov/ct2/show/NCT01036061
Palabras clave
Versiones (1)
- 18/5/18 18/5/18 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
18 de mayo de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Tolerability, pharmacokinetics, and brain Dopamine D3 receptor occupancy of increasing repeat doses of GSK618334 in healthy adults NCT01036061
Pharmacokinetics Urine
- StudyEvent: ODM
Similar models
Pharmacokinetics Urine
- StudyEvent: ODM
C0042036 (UMLS CUI-2)
C0022885 (UMLS CUI-3)
C0031328 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,3])
C0031328 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,3])
C0200354 (UMLS CUI [1,2])